Literature for apstatin (M24.005 inhibitor)

(Topics flags: S Structure, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2015
1. Hye Khan,M.A., Sharma,A., Rarick,K.R., Roman,R.J., Harder,D.R. and Imig,J.D.
   Elevated aminopeptidase P attenuates cerebral arterial responses to bradykinin in fawn-hooded hypertensive rats
   PLoS ONE10, e0145335-e0145335. PubMed  Europe PubMed DOI  I
2. Iyer,S., La-Borde,P.J., Payne,K.A., Parsons,M.R., Turner,A.J., Isaac,R.E. and Acharya,K.R.
   Crystal structure of X-prolyl aminopeptidase from Caenorhabditis elegans: a cytosolic enzyme with a di-nuclear active site
   FEBS Open Bio5, 292-302. PubMed  Europe PubMed DOI  S  I
2004
3. Graham,S.C., Maher,M.J., Simmons,W.H., Freeman,H.C. and Guss,J.M.
   Structure of Escherichia coli aminopeptidase P in complex with the inhibitor apstatin
   Acta Crystallogr D Biol Crystallogr60, 1770-1779. PubMed  Europe PubMed DOI  S  I
1999
4. [YEAR:1-7-1999]Maggiora,L.L., Orawski,A.T. and Simmons,W.H.
   Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme
   J Med Chem42, 2394-2402. PubMed  Europe PubMed DOI  I
1997
5. Ersahin,C. and Simmons,W.H.
   Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation
   J Cardiovasc Pharmacol30, 96-101. PubMed  Europe PubMed DOI  I
1995
6. Prechel,M.M., Orawski,A.T., Maggiora,L.L. and Simmons,W.H.
   Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung
   J Pharmacol Exp Ther275, 1136-1142. PubMed  Europe PubMed  I